Share this post on:

Product Name :
Quabodepistat

Search keywords :
Quabodepistat

drugId :
null

Target Vo:
FAD-dependent decaprenylphosphoryl-beta-D-ribofuranose 2-oxidase

Target Vo Short Name :
DprE1

Moa_Name:
FAD-dependent decaprenylphosphoryl-beta-D-ribofuranose 2-oxidase inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Otsuka Holdings Co Ltd

Active Company_Name :
Otsuka Pharmaceutical Co Ltd

Active Indication_Name:
Tuberculosis, Pulmonary

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
HSP60 Antibody
NEDD8 Antibody
NF-κB p65 Antibody: NF-κB p65 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 65 kDa, targeting to NF-κB p65. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse.

Share this post on:

Author: Interleukin Related